Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.30
+0.10 (0.25%)
Oct 31, 2025, 4:08 PM HKT

HKG:2627 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
323.76259.6152.17
Revenue Growth (YoY)
-397.65%-
Cost of Revenue
105.9108.1672.51
Gross Profit
217.86151.46-20.34
Selling, General & Admin
216.45199.81132.39
Research & Development
203.96204.62280.86
Other Operating Expenses
0.112.97-
Operating Expenses
420.55407.47413.3
Operating Income
-202.7-256.01-433.65
Interest Expense
-20.23-17.71-6.61
Interest & Investment Income
0.240.473.16
Other Non Operating Income (Expenses)
-6.3415.3511.04
EBT Excluding Unusual Items
-229.03-257.9-426.05
Gain (Loss) on Sale of Investments
0.010.241.35
Gain (Loss) on Sale of Assets
-0.88-1.06-0.04
Pretax Income
-224.43-258.72-424.74
Net Income
-224.43-258.72-424.74
Net Income to Common
-224.43-258.72-424.74
Shares Outstanding (Basic)
360360360
Shares Outstanding (Diluted)
360360360
EPS (Basic)
-0.62-0.72-1.18
EPS (Diluted)
-0.62-0.72-1.18
Free Cash Flow
-229.07-399.08-571.29
Free Cash Flow Per Share
-0.64-1.11-1.59
Gross Margin
67.29%58.34%-39.00%
Operating Margin
-62.61%-98.61%-831.25%
Profit Margin
-69.32%-99.66%-814.18%
Free Cash Flow Margin
-70.75%-153.72%-1095.09%
EBITDA
-145.92-206.54-394.1
EBITDA Margin
-45.07%-79.56%-
D&A For EBITDA
56.7849.4739.54
EBIT
-202.7-256.01-433.65
EBIT Margin
-62.61%-98.61%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.